CP 424391

Known as: CP-424,391, CP-424391 
 

Topic mentions per year

Topic mentions per year

2001-2008
012320012008

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2009
Review
2009
AIMS This review describes clinical results of gastrointestinal intubation studies of eight controlled release (CR) candidates… (More)
Is this relevant?
2008
2008
Increasing beta-amyloid (Abeta) clearance may alter the course of Alzheimer's disease progression and attenuate amyloid plaque… (More)
Is this relevant?
2005
2005
CP-424391, 2-amino-N-[3aR-benzyl-2-methyl-3-oxo-2,3,3a,4,6,7-hexahydro-pyrazolo[4,3-c]pyridin-5-yl)-1R-benzyloxymethyl-2-oxoethyl… (More)
  • figure 1
  • figure 2
  • table 1
  • table 2
  • figure 3
Is this relevant?
2003
2003
Novel pyrazolinone-piperidine dipeptide derivatives were synthesized and evaluated as growth hormone secretagogues (GHSs). Two… (More)
Is this relevant?
2001
2001
The cardioprotective efficacy of the pyrazolinone-piperidine dipeptide growth hormone secretagogue (GHS) CP-424,391 was studied… (More)
Is this relevant?
2001
2001
Growth hormone secretagogues (GHSs) represent attractive therapeutic alternatives to recombinant growth hormone (GH), given their… (More)
Is this relevant?
2001
2001
BACKGROUND Exogenous administration of growth hormone (GH) and subsequently increased production of insulin-like growth factor-1… (More)
  • figure 1
  • figure 2
  • table 1
  • table 2
Is this relevant?